Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Clinical trial NCT00272454 · COMPLETED

Trial details

NCT number: NCT00272454
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cerebral Infarction

Start date: 2006-01-01
Enrollment: 468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.